Sort
82,697 grants matching “vaccine development”
Research, Development and Production to Support Clinical Trials for HIV Vaccines
$5,300,000David Lindsay · Leidos Biomedical Research, Inc. · N01 · FY2016 · CA
Harnessing Human DC Subsets for Improved Muscosal Vaccines
$5,292,047Jacques F Banchereau · Baylor Research Institute · U19 · FY2009 · AI
Discovery of novel Henipavirus inhibitors
$5,291,771Thomas William Geisbert · University Of Texas Med Br Galveston · U19 · FY2022 · AI
Multiscale analysis of influenza host-pathogen interactions: Fluomics
$5,286,096Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · U19 · FY2014 · AI
NIAID Centers of Excellence for Influenza Research and Response: Universal Influenza Vaccine Research Activities
$5,276,000Adolfo Garcia-Sastre · Icahn School Of Medicine At Mount Sinai · N01 · FY2025 · AI
Project 2: Current Good Manufacture Practices (CGMP) Production of Nucleoside-Modified mRNAs Encoding HIV-1 Envelopes
$5,274,388Frederick Porter · Duke University · U19 · FY2022 · AI
Cancer Center Support Grant
$5,266,903Michael A Teitell · University Of California Los Angeles · P30 · FY2020 · CA
Cancer Center Support Grant
$5,266,903Michael A Teitell · University Of California Los Angeles · P30 · FY2021 · CA
Cancer Center Support Grant
$5,266,903Michael A Teitell · University Of California Los Angeles · P30 · FY2023 · CA
Cancer Center Support Grant
$5,266,903Michael A Teitell · University Of California Los Angeles · P30 · FY2022 · CA
Cancer Center Support Grant
$5,266,903Michael A Teitell · University Of California Los Angeles · P30 · FY2024 · CA
Indiana Clinical and Translational Sciences Institute
$5,260,393Sharon M Moe · Indiana University Indianapolis · UM1 · FY2025 · TR
HIV IMPAACT RELATED STUDIES
$5,258,594Barbara Driver · Westat, Inc. · N01 · FY2019 · HD
Development of Improved DNA Vaccines and Electroporation Delivery Devices for HIV
$5,258,144Niranjan Sardesai · Viral Genomix, Inc. · N01 · FY2010 · AI
SURGERY, IMMUNOLOGY AND IMMUNOTHERAPY OF HUMAN CANCER
$5,257,001Donald L Morton · Saint John'S Cancer Institute · P01 · FY2006 · CA
A prospective study of critical environmental exposures in formative early life that impact lifelong health in rural US children: the New Hampshire Birth Cohort Study
$5,255,245Margaret Rita Karagas · Dartmouth College · UH3 · FY2020 · OD
A prospective study of critical environmental exposures in formative early life that impact lifelong health in rural US children: the New Hampshire Birth Cohort Study
$5,255,245Margaret Rita Karagas · Dartmouth College · UH3 · FY2022 · OD
A prospective study of critical environmental exposures in formative early life that impact lifelong health in rural US children: the New Hampshire Birth Cohort Study
$5,255,245Margaret Rita Karagas · Dartmouth College · UH3 · FY2021 · OD
A prospective study of critical environmental exposures in formative early life that impact lifelong health in rural US children: the New Hampshire Birth Cohort Study
$5,254,924Margaret Rita Karagas · Dartmouth College · UH3 · FY2018 · OD
Adjuvant Development of the TLR4 Ligand BECC470s For Use in Influenza, S. aureus, and P. aeruginosa Vaccines
$5,246,827Gregory Sorenson · University Of Maryland Baltimore County · N01 · FY2024 · AI
University of North Carolina Global HIV Prevention and Treatment Clinical Trials
$5,246,488Joseph J. Eron · Univ Of North Carolina Chapel Hill · UM1 · FY2020 · AI
Vanderbilt Vaccine and Treatment Evaluation Unit - KidCOVE
$5,245,366Clarence Buddy Creech · Vanderbilt University Medical Center · UM1 · FY2021 · AI
Immunologic and Virologic Basis of RhCMV/SIV Vaccine-Induced Replication Arrest Efficacy
$5,243,013Louis J. Picker · Oregon Health & Science University · P01 · FY2025 · AI
Simian Vaccine Evaluation Unit (SVEU)
$5,229,662Phillip D Markham · Advanced Bioscience Laboratories, Inc. · N01 · FY2010 · AI
Vaccines and Therapeutics Technology Core
$5,228,898Robert H Carnahan · Vanderbilt University Medical Center · U19 · FY2024 · AI